Telix Pharmaceuticals Ltd(TLPPF) News

Date	Title
Jul 18	First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib